RecruitingNot applicableNCT07307976

The Analgesic Efficacy and Safety of Crisugabalin in Patients With Herpes Zoster

Studying Infectious disease of the nervous system

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Tiantan Hospital
Intervention
Crisugabalin combined conventional therapy(drug)
Enrollment
750 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07307976 on ClinicalTrials.gov

Other trials for Infectious disease of the nervous system

Additional recruiting or active studies for the same condition.

See all trials for Infectious disease of the nervous system

← Back to all trials